Evidence map›Paper›PMID 32792685›Full record

ArticleOncogene2020

BRAF

Nadine Reischmann, Geoffroy Andrieux, Ricarda Griffin, Thomas Reinheckel, Melanie Boerries, Tilman Brummer

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. BRAFiScience · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Application Progress of Organoids in Colorectal Cancer.Frontiers in cell and developmental biology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nadine ReischmannInstitute of Molecular Medicine and Cell Research (IMMZ), University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0003-3228-053X
Geoffroy AndrieuxInstitute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
Ricarda GriffinInstitute of Molecular Medicine and Cell Research (IMMZ), University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0003-1368-2832
Thomas ReinheckelInstitute of Molecular Medicine and Cell Research (IMMZ), University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0001-9866-9105
Melanie BoerriesInstitute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
Tilman BrummerInstitute of Molecular Medicine and Cell Research (IMMZ), University of Freiburg, Freiburg, Germany. tilman.brummer@mol-med.uni-freiburg.de.ORCID http://orcid.org/0000-0003-4387-7905
University of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BRAF

Indexed as

Genes, APCGenetic Predisposition to DiseaseMutationAnimalsCell DedifferentiationCell Transformation, NeoplasticColonColorectal NeoplasmsComputational BiologyDisease Models, AnimalGene Expression ProfilingGene Expression Regulation, NeoplasticGenetic Association StudiesHumansIntestine, SmallMAP Kinase Signaling SystemProto-Oncogene Proteins B-rafTumor Suppressor Protein p53

Identifiers

PMID32792685
PMCPMC7498370
OpenAlexW3048789188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.